臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 2818311
	???header.visitor??? : 28021668 ???header.onlineuser??? : 588 ???header.sponsordeclaration???

???search.scope???

???search.advance???

???search.login???

???search.administrator???

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pu y s"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-10 of 627 (63 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2022-09-15T01:09:59Z	A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer	Chia-Chi Lin; Hsu C.-H.; Chen J.; Tsai T.-C.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:58Z	Changing trends of prostate cancer in Asia	Pu Y.-S.; Chiang H.-S.; Chia-Chi Lin; Huang C.-Y.; Huang K.-H.; Chen J.
臺大學術典藏	2022-09-15T01:09:58Z	Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide	Hour T.-C.; Huang C.-Y.; Chia-Chi Lin; Chen J.; Guan J.-Y.; Lee J.-M.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:57Z	Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer	Hour T.-C.; Pu Y.-S.; Chia-Chi Lin; Huang S.-W.; Chen J.; Chiu A.W.; Chen C.-J.; Huang C.-Y.
臺大學術典藏	2022-09-15T01:09:57Z	Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells	Pu Y.-S.; Hsieh M.-W.; Wang C.-W.; Liu G.-Y.; Huang C.-Y.; Chia-Chi Lin; Guan J.-Y.; Lin S.-R.; Hour T.-C.
臺大學術典藏	2022-09-15T01:09:56Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:56Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Cheng A.-L.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:56Z	Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study	Chia-Chi Lin; Hsu C.-H.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:54Z	Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏	2022-09-15T01:09:54Z	Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens	Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.

Showing items 1-10 of 627 (63 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page